Chemomab Therapeutics Ltd.

NasdaqCM:CMMB Stock Report

Market Cap: US$30.2m

Chemomab Therapeutics Ltd. Company Information

Chemomab Therapeutics Ltd.'s employee growth, exchange listings and data sources

Key Information

  • Name: Chemomab Therapeutics Ltd.
  • Ticker: CMMB
  • Exchange: NasdaqCM
  • Founded: 2011
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$30.171m
  • Shares Outstanding: 18.86m
  • Website: https://www.chemomab.com

Number of Employees

Location

  • Chemomab Therapeutics Ltd.
  • Building 7
  • Kiryat Atidim
  • Tel Aviv
  • 6158002
  • Israel

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CMMBNasdaqCM (Nasdaq Capital Market)YesSPON ADS EACH REP 20 ORD SHSUSUSDMar 2021
2QV0DB (Deutsche Boerse AG)YesSPON ADS EACH REP 20 ORD SHSDEEURMar 2021

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/22 23:32
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.